At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 299 enrolled
Drug / intervention
Bromfenac Ophthalmic Solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
In Brief
A Phase 3 clinical trial evaluating Bromfenac Ophthalmic Solution and Placebo Comparator for Pain and Inflammation. Completed, enrolled 299 participants across 1 site.
Detailed Summary
Efficacy study of Bromfenac Ophthalmic Solution in cataract surgery
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Inflammation
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
First PostedMar 2009
Primary CompletionSep 2009
Study CompletionDec 2009
TodayJul 2026
First PostedMar 2, 2009
Enrollment StartFeb 1, 2009
Primary CompletionSep 1, 2009
Study CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 17.3 years ago
Interventions
Bromfenac Ophthalmic Solutiondrug
sterile ophthalmic solution
Placebo Comparatordrug
sterile ophthalmic solution